Latest filing published 16 Sept 2020 for Mersana Therapeutics, Inc..
Insider track record
No signal scores available.
NEA Partners 14, L.P.: trading record in brief
NEA Partners 14, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mersana Therapeutics, Inc. and Appian Corp. In total, 10 filings cover trades dated from 13 February 2018 to 14 September 2020.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 16 September 2020, reports a transaction in Mersana Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to NEA Partners 14, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares0Common StockSEC:0001209191-20-050711:0
- 20,000 shares0Common StockSEC:0001209191-20-050711:1
- 20,000 shares0Common StockSEC:0001209191-20-050711:2
- 4,000,000 shares0Common StockSEC:0001209191-20-024296:0
- 40,000 shares0Common StockSEC:0001209191-20-024296:1
- 40,000 shares0Common StockSEC:0001209191-20-024296:2
- 2,724,202 sharesClass A Common StockSEC:0001209191-18-010399:0
- 2,724,202 shares0Class A Common StockSEC:0001209191-18-010399:1
- 27,242 shares0Class A Common StockSEC:0001209191-18-010399:2
- 27,242 shares0Class A Common StockSEC:0001209191-18-010399:3
10 of 10 declarations
